Bioblast Pharma

Hope should not be rare

Board of directors

The Board of Directors of Bioblast Pharma

The foundation for a better future: for patients and Bioblast Pharma

At Bioblast Pharma, our Board of Directors is committed to ensuring the company remains firm in its pursuit to improve lives affected by rare and ultra-rare diseases. The extensive experiences of our directors will help uphold the company’s integrity, as Bioblast Pharma delivers on the promise to make a difference in the orphan disease communities.

Learn about the members of the Board of Directors of Bioblast
  • Fredric Price

    Executive Chairman of the Board of Directors

    Fredric Price has been Executive Chairman of our Board of Directors since April 2014, having served as Chairman of the Board of Directors from April 2012 until April 2014.

    Learn more
  • Michael Burshtine, MBA, CPA

    Bioblast Pharma Board of Directors Member

    Michael (Mike) Burshtine joined the Bioblast Pharma Board of Directors in September 2014.

    Learn more
  • Thomas I. H. Dubin

    Thomas I.H. Dubin

    Bioblast Pharma Board of Directors Member

    Thomas (Tom) Dubin joined our Board in September 2015.

    Learn more
  • Colin Foster

    Colin Foster

    Bioblast Pharma Board of Directors Member

    Colin Foster served as President and CEO of Bioblast Pharma from January 2015 through June 2016 and as director since January 2015.

    Learn more
  • Robert Friedman

    Bioblast Pharma Board of Directors Member

    Robert Friedman joined the Bioblast Pharma Board of Directors in October 2016.

    Learn more
  • Marlene Haffner

    Marlene Haffner, MD, MPH

    Bioblast Pharma Board of Directors Member

    Dr. Marlene Haffner has been a Bioblast director since July 1, 2013.

    Learn more
  • Dalia Megiddo

    Dalia Megiddo, MD, MBA

    Bioblast Pharma Board of Directors Member and Co-founder

    Dr. Dalia Megiddo is Bioblast Pharma’s co-founder.

    Learn more
  • Ran Nussbaum

    Ran Nussbaum

    Bioblast Pharma Board of Directors Member

    Ran Nussbaum has been a director at Bioblast since July 1, 2013.

    Learn more
  • Ralf Rosskamp, MD, PhD

    Bioblast Pharma Board of Directors Member

    Dr. Rosskamp is a pediatric endocrinologist with over 15 years of experience in clinical medicine and almost 20 years of experience in the pharmaceutical industry.

    Learn more